Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to compare the efficacy of various treatment options for eliminating nasal telangiectasias. The study will compare the outcome of treating nasal telangiectasias with the following; no treatment (control site), alexandrite laser, pulsed dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and electrosurgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02090517
Study type Interventional
Source University of California, Davis
Contact
Status Withdrawn
Phase N/A
Start date June 2014
Completion date February 2016

See also
  Status Clinical Trial Phase
Withdrawn NCT00406380 - Effect of Avastin in Juxtafoveal Telangiectasias Phase 3
Completed NCT00005392 - Epidemiology of Venous Disease N/A
Completed NCT00005386 - Biobehavioral Determinants of Obesity in Black Women N/A
Completed NCT01205035 - High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia Phase 2
Completed NCT01362192 - Treatment of Lower Extremity Spider Veins With Excel V Phase 4
Completed NCT00725244 - Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias Phase 4
Completed NCT02657252 - Polidocanol Versus Glucose Treatment of Telangiectasia Trial Phase 4
Completed NCT02104271 - Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. Phase 2
Completed NCT00451763 - Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia Phase 3
Completed NCT05860439 - Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias
Recruiting NCT00206921 - Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness N/A